2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial

M Bachner; Y Loriot; M Gross-Goupil; P A Zucali; A Horwich; J-R Germa-Lluch; C Kollmannsberger; F Stoiber; A Fléchon; K Oechsle; S Gillessen; J Oldenburg; G Cohn-Cedermark; G Daugaard; F Morelli; A Sella; S Harland; M Kerst; J Gampe; Carsten Dittrich; K Fizazi; M De Santis

doi:10.1093/annonc/mdr052

2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial

M Bachner, Y Loriot, M Gross-Goupil, P A Zucali, A Horwich, J-R Germa-Lluch, C Kollmannsberger, F Stoiber, A Fléchon, K Oechsle, S Gillessen, J Oldenburg, G Cohn-Cedermark, G Daugaard, F Morelli, A Sella, S Harland, M Kerst, J Gampe, Carsten DittrichK Fizazi, M De Santis

124 Citationer (Scopus)

Abstract

2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) has been recommended in international guidelines in the evaluation of postchemotherapy seminoma residuals. Our trial was designed to validate these recommendations in a larger group of patients.

Originalsprog	Engelsk
Tidsskrift	Annals of Oncology
Vol/bind	23
Udgave nummer	1
Sider (fra-til)	59-64
Antal sider	6
ISSN	0923-7534
DOI	https://doi.org/10.1093/annonc/mdr052
Status	Udgivet - 2012

Adgang til dokumentet

10.1093/annonc/mdr052

Citationsformater

Bachner, M., Loriot, Y., Gross-Goupil, M., Zucali, P. A., Horwich, A., Germa-Lluch, J.-R., Kollmannsberger, C., Stoiber, F., Fléchon, A., Oechsle, K., Gillessen, S., Oldenburg, J., Cohn-Cedermark, G., Daugaard, G., Morelli, F., Sella, A., Harland, S., Kerst, M., Gampe, J., ... De Santis, M. (2012). 2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial. Annals of Oncology, 23(1), 59-64. https://doi.org/10.1093/annonc/mdr052

Bachner, M, Loriot, Y, Gross-Goupil, M, Zucali, PA, Horwich, A, Germa-Lluch, J-R, Kollmannsberger, C, Stoiber, F, Fléchon, A, Oechsle, K, Gillessen, S, Oldenburg, J, Cohn-Cedermark, G, Daugaard, G, Morelli, F, Sella, A, Harland, S, Kerst, M, Gampe, J, Dittrich, C, Fizazi, K & De Santis, M 2012, '2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial', Annals of Oncology, bind 23, nr. 1, s. 59-64. https://doi.org/10.1093/annonc/mdr052

@article{43fcc7581f0c40bdad2d7b6cacbef3e5,

title = "2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial",

abstract = "2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) has been recommended in international guidelines in the evaluation of postchemotherapy seminoma residuals. Our trial was designed to validate these recommendations in a larger group of patients.",

keywords = "Glucose-6-Phosphate, Humans, Male, Positron-Emission Tomography, Radiopharmaceuticals, Retrospective Studies, Seminoma, Sensitivity and Specificity, Testicular Neoplasms",

author = "M Bachner and Y Loriot and M Gross-Goupil and Zucali, {P A} and A Horwich and J-R Germa-Lluch and C Kollmannsberger and F Stoiber and A Fl{\'e}chon and K Oechsle and S Gillessen and J Oldenburg and G Cohn-Cedermark and G Daugaard and F Morelli and A Sella and S Harland and M Kerst and J Gampe and Carsten Dittrich and K Fizazi and {De Santis}, M",

year = "2012",

doi = "10.1093/annonc/mdr052",

language = "English",

volume = "23",

pages = "59--64",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Limited",

number = "1",

}

TY - JOUR

T1 - 2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions

T2 - a retrospective validation of the SEMPET trial

AU - Bachner, M

AU - Loriot, Y

AU - Gross-Goupil, M

AU - Zucali, P A

AU - Horwich, A

AU - Germa-Lluch, J-R

AU - Kollmannsberger, C

AU - Stoiber, F

AU - Fléchon, A

AU - Oechsle, K

AU - Gillessen, S

AU - Oldenburg, J

AU - Cohn-Cedermark, G

AU - Daugaard, G

AU - Morelli, F

AU - Sella, A

AU - Harland, S

AU - Kerst, M

AU - Gampe, J

AU - Dittrich, Carsten

AU - Fizazi, K

AU - De Santis, M

PY - 2012

Y1 - 2012

N2 - 2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) has been recommended in international guidelines in the evaluation of postchemotherapy seminoma residuals. Our trial was designed to validate these recommendations in a larger group of patients.

AB - 2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) has been recommended in international guidelines in the evaluation of postchemotherapy seminoma residuals. Our trial was designed to validate these recommendations in a larger group of patients.

KW - Glucose-6-Phosphate

KW - Humans

KW - Male

KW - Positron-Emission Tomography

KW - Radiopharmaceuticals

KW - Retrospective Studies

KW - Seminoma

KW - Sensitivity and Specificity

KW - Testicular Neoplasms

U2 - 10.1093/annonc/mdr052

DO - 10.1093/annonc/mdr052

M3 - Journal article

C2 - 21460378

SN - 0923-7534

VL - 23

SP - 59

EP - 64

JO - Annals of Oncology

JF - Annals of Oncology

IS - 1

ER -

2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater